These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 34651344)

  • 1. Bioinspired and Biomimetic Delivery Platforms for Cancer Vaccines.
    Liu J; Liew SS; Wang J; Pu K
    Adv Mater; 2022 Jan; 34(1):e2103790. PubMed ID: 34651344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomimetic and bioinspired nano-platforms for cancer vaccine development.
    Feng C; Tan P; Nie G; Zhu M
    Exploration (Beijing); 2023 Jun; 3(3):20210263. PubMed ID: 37933383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine-like nanomedicine for cancer immunotherapy.
    Yi Y; Yu M; Li W; Zhu D; Mei L; Ou M
    J Control Release; 2023 Mar; 355():760-778. PubMed ID: 36822241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinspired and Biomimetic Gene Delivery Systems.
    Tuyen Ho M; Barrett A; Wang Y; Hu Q
    ACS Appl Bio Mater; 2024 Aug; 7(8):4914-4922. PubMed ID: 37905498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of biomimetic nanovaccines in cancer immunotherapy: A useful strategy to help combat immunotherapy resistance.
    Xu Z; Zhou H; Li T; Yi Q; Thakur A; Zhang K; Ma X; Qin JJ; Yan Y
    Drug Resist Updat; 2024 Jul; 75():101098. PubMed ID: 38833804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. At the bench: Engineering the next generation of cancer vaccines.
    Shae D; Baljon JJ; Wehbe M; Becker KW; Sheehy TL; Wilson JT
    J Leukoc Biol; 2020 Oct; 108(4):1435-1453. PubMed ID: 31430398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomaterials for vaccine-based cancer immunotherapy.
    Zhang R; Billingsley MM; Mitchell MJ
    J Control Release; 2018 Dec; 292():256-276. PubMed ID: 30312721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Changing Landscape of Therapeutic Cancer Vaccines-Novel Platforms and Neoantigen Identification.
    Jou J; Harrington KJ; Zocca MB; Ehrnrooth E; Cohen EEW
    Clin Cancer Res; 2021 Feb; 27(3):689-703. PubMed ID: 33122346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle mediated cancer immunotherapy.
    Gupta J; Safdari HA; Hoque M
    Semin Cancer Biol; 2021 Feb; 69():307-324. PubMed ID: 32259643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinspired and Biomimetic Nanomedicines.
    Chen Z; Wang Z; Gu Z
    Acc Chem Res; 2019 May; 52(5):1255-1264. PubMed ID: 30977635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unlocking the power of nanomedicine: Cell membrane-derived biomimetic cancer nanovaccines for cancer treatment.
    Zhao G; Wang S; Nie G; Li N
    Med; 2024 Jul; 5(7):660-688. PubMed ID: 38582088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Advances in Cell Membrane-Derived Biomimetic Nanotechnology for Cancer Immunotherapy.
    Raza F; Zafar H; Zhang S; Kamal Z; Su J; Yuan WE; Mingfeng Q
    Adv Healthc Mater; 2021 Mar; 10(6):e2002081. PubMed ID: 33586322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-Targeted Nanomedicine for Immunotherapy.
    Cabral H; Kinoh H; Kataoka K
    Acc Chem Res; 2020 Dec; 53(12):2765-2776. PubMed ID: 33161717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in Engineering Cells for Cancer Immunotherapy.
    Xu X; Li T; Shen S; Wang J; Abdou P; Gu Z; Mo R
    Theranostics; 2019; 9(25):7889-7905. PubMed ID: 31695806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in Cancer Vaccine Research.
    Liu N; Xiao X; Zhang Z; Mao C; Wan M; Shen J
    ACS Biomater Sci Eng; 2023 Nov; 9(11):5999-6023. PubMed ID: 37921277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-localized delivery of nanomedicine and nanovaccine augments the postoperative cancer immunotherapy by amplifying T-cell responses.
    Liu X; Feng Z; Wang C; Su Q; Song H; Zhang C; Huang P; Liang XJ; Dong A; Kong D; Wang W
    Biomaterials; 2020 Feb; 230():119649. PubMed ID: 31791843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving Cancer Vaccine Efficiency by Nanomedicine.
    Cai J; Wang H; Wang D; Li Y
    Adv Biosyst; 2019 Mar; 3(3):e1800287. PubMed ID: 32627400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced Generation Therapeutics: Biomimetic Nanodelivery System for Tumor Immunotherapy.
    Li J; Zeng H; Li L; Yang Q; He L; Dong M
    ACS Nano; 2023 Dec; 17(24):24593-24618. PubMed ID: 38055350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomimetic nanoparticles for DC vaccination: a versatile approach to boost cancer immunotherapy.
    Meng L; Teng Z; Yang S; Wang N; Guan Y; Chen X; Liu Y
    Nanoscale; 2023 Apr; 15(14):6432-6455. PubMed ID: 36916703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanobiomaterial-based vaccination immunotherapy of cancer.
    Chen F; Wang Y; Gao J; Saeed M; Li T; Wang W; Yu H
    Biomaterials; 2021 Mar; 270():120709. PubMed ID: 33581608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.